Voloridge Investment Management, LLC Humanigen, Inc Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.76 - $3.33 $585,935 - $1.11 Million
-332,918 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.81 - $3.97 $574,856 - $1.26 Million
-317,600 Reduced 48.82%
332,918 $1 Million
Q4 2021

Feb 14, 2022
BUY
$3.66 - $8.22 $454,550 - $1.02 Million
124,194 Added 23.6%
650,518 $2.42 Million
Q3 2021

Nov 15, 2021
BUY
$5.93 - $17.83 $3.12 Million - $9.38 Million
526,324 New
526,324 $3.12 Million

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email